Related Experiment Video
Updated: May 8, 2026
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
Morbid obesity does not disadvantage patients with in situ or early-stage carcinoma undergoing breast-conserving
Federico Ampil1, Gloria Caldito, Benjamin Li
1Division of Therapeutic Radiology, Louisiana State University Health, 1501 Kings Highway, Shreveport, LA 71130, U.S.A. fampil@lsuhsc.edu.
Aim:
To determine whether morbidly obese (MO) patients with early-stage breast cancer (BCa) benefit from standard-of-care interventions.
Patients And Methods:
Between 1992 and 2005, 100 patients underwent breast-conserving surgery and postoperative whole-breast irradiation of 50 Gy for minimally invasive BCa with tumor-free surgical margins. Twenty-seven MO women were compared to 73 non-morbidly obese (NMO) patients.
Results:
At 10 years, the cumulative disease-free survival rate for the NMO patients was 91% compared to the non-statistically significant lower rate of 89% in the MO women (p=0.66). Patients who were excessively obese were not at an increased risk for local (p=0.99) or regional disease recurrence (p=0.29).
Conclusion:
The results suggest that patients with minimally invasive BCa and excessively large body habitus should not be disqualified from receiving breast-conserving therapy.
